Xenogen Corporation

Company details

Xenogen Corporation

Alameda, CA
US (United States)

Xenogen Corporation in Alameda, CA, US (United States) - Biomedical Research, Biotechnological Research and Development, Charged Coupled Device (CCD) Cameras, Computer Software, Database, Pharmaceutical Information, Drug Discovery, Photonic Detectors, Digital Imaging, Electronic Imaging, Imaging

Company details

TEL: +877 936 6436 FAX: +510 291 6196
http://www.xenogenbiosciences.com

Update this company

Company location:

Xenogen Corporation

Alameda, CA
US (United States)

Xenogen Corporation in Alameda, CA, US (United States) - Charged Coupled Device (CCD) Cameras, Biomedical Statistical Analysis Software, Imaging Systems, Microorganisms available from Xenogen Corporation based in Alameda, CA. Click the links below to visit our website or contact us via our profile

Company details

TEL: +877 936 6436
http://www.lpta.com

Update this company

Company location:

» View all 2 companies

News and Blogs

Total : 73 View more »

Press Releases: Xenogen Announcements, Conferences, Financial Results, Earnings Calls

Xenogen Corporation, a leader and innovator in the field of real-time in vivo imaging, today announced it has entered into an evaluation licensing agreement with DuPont Pharmaceuticals, a worldwide pharmaceutical company.

http://www.xenogen.com/wt/page/press/pr_1120077514

Xenogen Corporation

Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content. Terms and conditions, including restrictions on redistribution, apply. Copyright © 1996-2006 PR Newswire Association LLC. ALL Rights Reserved. A United Business Media company.

http://www.prnewswire.com/gh/cnoc/comp/902129.html

Xenogen releases software for bio research, Small Times - May 17, 2005

The software is compatible with Xenogen's existing imaging systems and represents the first release in the company's developing platform of 3D imaging capabilities.

http://www.smalltimes.com/articles/stm_print_screen.cfm?ARTICLE_ID=270058

Delphi Ventures

Alameda, California, July 16, 2004 - Xenogen Corporation (Nasdaq: XGEN) announced today the initial public offering of 4,200,000 shares of common stock at a price of $7.00 per share. All of the shares are being sold by the Company.

http://www.delphiventures.com/news/newsitem.php?file=.\txt\20040716.txt

Web Sites

Total : 100 View more »

Xenogen Corporation, Now part of Caliper Life Sciences: Breakthrough Technologies into Living

Utilize in vivo biophotonic imaging and an array of light producing biology products to non-invasively illuminate biological processes within living mammals.

http://www.xenogen.com/

Novascreen, A Caliper Life Sciences Company – Drug Discovery ; Preclinical drug development - Drug

NovaScreen Biosciences, an in vitro drug discovery service provider and Xenogen Biosciences, a provider of in vivo drug development services have combined under a new name, Caliper Discovery Alliances & Services (CDAS).

http://www.novascreen.com/

Nanolunch- a network meeting over free lunch

A weekly seminar and networking opportunity for business executives, entrepreneurs, scientists, engineers, and all professionals who are interested in the emerging field of nanotechnology, bionanotechnology and clean technology. Light lunch will be provided.

http://www.proyectando.com.ar/Nanolunch.htm

EuclidSR - Press Room

go to home page go to home page Euclid SR Partners Euclid SR Partners 06/20/2006 Rib-X Pharmaceuticals Raises $50 Million 06/01/2006 Rib-X Pharmaceuticals and Wakunaga Pharmaceutical Company Announce License Agreement for Quinolone Antibiotic 04/12/2006 Targacept Announces Pricing of its Initial

http://www.euclidpartners.com/pr.html